Women in England with breast cancer can opt for a medicine that buys “precious” time.
Women with advanced breast cancer in England will be able to benefit from a new type of immunotherapy at the NHS after a U-turn by the drug control dog. The National Institute for Health and Care Excellence (Nice) has overturned its draft rejection of Keytruda (pembrolizumab) and said women in England can take the drug …
Women in England with breast cancer can opt for a medicine that buys “precious” time. Read More »